We are live on ! Find out more
HCC

Hirtle Callaghan & Co Portfolio holdings

AUM $3.04B
1-Year Est. Return 21.27%
This Fund
S&P 500
This Quarter Est. Return
+4.74%
1 Year Est. Return
+21.27%
3 Year Est. Return
+58.14%
5 Year Est. Return
+50.47%
10 Year Est. Return
+146.76%
AUM
$432M
AUM Growth
-$172M
Cap. Flow
-$187M
Cap. Flow %
-43.4%
Top 10 Hldgs %
49.68%
Holding
678
New
118
Increased
50
Reduced
76
Closed
104

Sector Composition

Rank Sector Weight
1 Consumer Staples 36.48%
2 Miscellaneous 13.49%
3 Financials 11.17%
4 Energy 8.92%
5 Technology 8.42%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
CVS icon
151
CVS Health
CVS
$124B
$280K 0.06%
2,906
ACN icon
152
Accenture
ACN
$114B
$278K 0.06%
3,118
+1,551
+99% +$129K
FFBC icon
153
First Financial Bancorp
FFBC
$3.46B
$277K 0.06%
14,769
PARA
154
DELISTED
Paramount Global Class B
PARA
$268K 0.06%
4,838
ET icon
155
Energy Transfer Partners
ET
$74B
$267K 0.06%
9,300
+3,850
+71% +$111K
WES
156
DELISTED
Western Gas Partners Lp
WES
$264K 0.06%
3,611
MON
157
DELISTED
Monsanto Co
MON
$259K 0.06%
2,167
C icon
158
Citigroup
C
$231B
$254K 0.06%
4,700
-33
-0.7% -$1.75K
STT.PRE.CL
159
DELISTED
State Street Corporation Depository Shares, each representing a 1/4,000th ownership interest in a sh
STT.PRE.CL
$252K 0.06%
+10,000
New +$250K
VTR icon
160
Ventas
VTR
$46.3B
$251K 0.06%
3,065
MANH icon
161
Manhattan Associates
MANH
$12.5B
$247K 0.06%
6,076
ROST icon
162
Ross Stores
ROST
$73.7B
$247K 0.06%
5,240
PPG icon
163
PPG Industries
PPG
$25B
$239K 0.06%
2,068
SLXP
164
DELISTED
SALIX PHARMACEUTICALS LTD DEL
SLXP
$230K 0.05%
+2,000
New +$242K
AGCO icon
165
AGCO
AGCO
$9.34B
$225K 0.05%
4,968
MCO icon
166
Moody's
MCO
$85.5B
$213K 0.05%
2,220
BAX icon
167
Baxter International
BAX
$13.4B
$211K 0.05%
5,252
TFCF
168
DELISTED
Twenty-First Century Fox, Inc. Class B
TFCF
$203K 0.05%
+5,500
New +$188K
WPZ
169
DELISTED
WILLIAMS PARTNERS L.P. COM UTS REPTG L.P. INT
WPZ
$203K 0.05%
4,815
CVSA
170
Covista Inc
CVSA
$4.36B
$200K 0.05%
4,220
AMZN icon
171
Amazon
AMZN
$2.79T
$197K 0.05%
12,720
CRH icon
172
CRH
CRH
$62.7B
$195K 0.05%
8,316
NGLS
173
DELISTED
TARGA RESOURCES PARTNERS LP COM UTS REPTG LTD PARTERSHIP INT
NGLS
$185K 0.04%
3,859
ASML icon
174
ASML
ASML
$659B
$182K 0.04%
1,690
-200
-11% -$20.3K
CHKP icon
175
Check Point Software Technologies
CHKP
$14B
$177K 0.04%
2,250

Similar funds

Hirtle Callaghan & Co's Q4 2014 Portfolio in Review

As of Q4 2014, Hirtle Callaghan & Co held 678 positions worth $432M, down 28% from $603M the previous quarter. Its ten largest holdings account for 50% of the portfolio.

Hirtle Callaghan & Co withdrew a net $187M in Q4 2014, closing 104 positions and reducing 76 holdings. Its most notable exit was iShares MSCI Emerging Markets ETF, an estimated $98.3M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 36% of assets, up from 25% a quarter earlier, followed by Miscellaneous and Financials.

Against the trend, Hirtle Callaghan & Co opened a new position in JPMorgan Chase worth $2.04M.

  • Hirtle Callaghan & Co's largest Q4 2014 buy was JPMorgan Chase: 32,530 shares worth $2.04M.
  • Hirtle Callaghan & Co added most to Kinder Morgan in Q4 2014, an estimated $4.36M increase.
  • Hirtle Callaghan & Co's biggest Q4 2014 reduction was Stryker, cutting an estimated $973K.
  • Hirtle Callaghan & Co fully exited iShares MSCI Emerging Markets ETF in Q4 2014, selling an estimated $98.3M.
  • Hirtle Callaghan & Co's ten largest holdings make up 50% of its $432M portfolio in Q4 2014.
  • Hirtle Callaghan & Co opened 118 new positions and closed 104 in Q4 2014.
  • Hirtle Callaghan & Co's portfolio value fell 28% quarter-over-quarter to $432M.

Based on Hirtle Callaghan & Co's 13F filing for Q4 2014, filed 26 Jan 2015.